Get comprehensive liver health assessment with the FIB-4 Index Test for only $12 USD. Non-invasive liver fibrosis screening available across USA including New York
Sale!

FIB-4 Index Test

Original price was: $14.Current price is: $12.

-14%

The FIB-4 Index Test is a non-invasive blood-based assessment that evaluates liver fibrosis risk using a validated mathematical formula combining age, AST, ALT, and platelet count. This advanced screening tool helps identify early-stage liver fibrosis without invasive procedures, providing crucial insights into liver health. The test is particularly valuable for individuals with risk factors for liver disease, including metabolic conditions, alcohol consumption, or viral hepatitis exposure. Results are typically available within 24 hours, and no special preparation is required. At only $12 USD, this affordable screening offers significant value for proactive liver health management. Early detection through FIB-4 testing can guide appropriate interventions and prevent progression to more serious liver conditions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

FIB-4 Index Test: Comprehensive Liver Fibrosis Assessment

Understanding the FIB-4 Index Test

The FIB-4 Index Test represents a groundbreaking advancement in non-invasive liver health assessment. This sophisticated diagnostic tool utilizes a validated mathematical algorithm to evaluate liver fibrosis risk, providing healthcare providers with crucial insights into liver condition without requiring invasive procedures. Developed through extensive clinical research, the FIB-4 index has become an essential component in modern hepatology practice, offering reliable screening for liver fibrosis across diverse patient populations.

What Does the FIB-4 Index Measure?

The FIB-4 Index calculates liver fibrosis probability by analyzing four key parameters:

  • Age: Considers the patient’s current age as fibrosis risk increases with advancing years
  • AST (Aspartate Aminotransferase): Measures liver enzyme levels indicating potential liver cell damage
  • ALT (Alanine Aminotransferase): Assesses another critical liver enzyme marker
  • Platelet Count: Evaluates blood platelet levels, which often decrease with advancing liver fibrosis

Who Should Consider FIB-4 Index Testing?

This advanced liver screening is particularly recommended for individuals experiencing:

  • Unexplained fatigue or persistent tiredness
  • Abdominal discomfort or swelling
  • History of elevated liver enzymes
  • Risk factors for non-alcoholic fatty liver disease (NAFLD)
  • Previous alcohol consumption concerns
  • Family history of liver conditions
  • Metabolic syndrome components including obesity or diabetes
  • Suspected viral hepatitis exposure

Clinical Benefits of FIB-4 Index Assessment

Choosing the FIB-4 Index Test provides numerous advantages for comprehensive liver health management:

  • Non-Invasive Screening: Eliminates the need for liver biopsy in initial assessment phases
  • Early Detection Capability: Identifies fibrosis risk before advanced liver damage occurs
  • Cost-Effective Monitoring: Provides affordable serial monitoring for at-risk individuals
  • Comprehensive Risk Stratification: Helps categorize patients into appropriate management pathways
  • Treatment Guidance: Informs decisions regarding further diagnostic testing or intervention
  • Proactive Health Management: Enables early intervention strategies for optimal outcomes

Understanding Your FIB-4 Test Results

Your FIB-4 Index results will fall into one of three primary categories:

Low Probability of Significant Fibrosis

Results below the established cutoff typically indicate minimal fibrosis risk. Regular monitoring and maintaining healthy lifestyle habits are generally recommended.

Intermediate Range Results

Scores in the intermediate range may warrant additional evaluation or closer monitoring, depending on individual risk factors and clinical presentation.

High Probability of Advanced Fibrosis

Elevated FIB-4 scores suggest higher likelihood of significant liver fibrosis, typically prompting referral to gastroenterology specialists for comprehensive assessment and management planning.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $12
Regular Price $14

Nationwide Testing Availability

GGC DNA maintains comprehensive testing facilities across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and numerous other cities. Our network ensures accessible liver health screening for patients nationwide.

Schedule Your FIB-4 Index Test Today

Take proactive control of your liver health with our advanced FIB-4 Index assessment. Our streamlined testing process requires minimal time commitment and provides rapid results to guide your healthcare decisions. Contact our dedicated scheduling team to arrange your comprehensive liver evaluation.

Call or WhatsApp: +1(267) 388-9828

Our experienced healthcare professionals are available to discuss the FIB-4 Index Test, answer your questions about liver health screening, and schedule your appointment at a convenient location near you. Early detection through advanced screening represents the most effective strategy for maintaining optimal liver function and preventing progressive liver disease.

SKU: 828 Category: